GGrantIndex
← Leaderboards

Elizabeth A Heller

University Of Pennsylvania

$8,280,996
Attributed
$8,280,996
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY201325
$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,280,996 · 6

By mechanism

R01$4,973,066 · 2
DP1$2,558,668 · 1
R41$405,230 · 1
U18$233,112 · 1
F32$110,920 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Rewards

Research focus

RewardsBehaviorGenetic TranscriptionGenesGene ExpressionCocaine ExposurePharmaceutical PreparationsNeuronsMolecularBrainModificationEpigenetic ProcessHistonesTranscription FactorGenome-WideAddictionChronicMediatingPublishingChromatinData SetMental DisordersMental DepressionPost-Translational Protein Processing

Grant awards (19)

Epigenetic mechanisms of sustained transcription across cocaine abstinence$625,371
R01 · FY2025 · DA · contact PI
Epigenetic regulation of Cdk5 in cognition and emotion$596,913
R01 · FY2025 · MH · contact PI
Advancing Nr4a1 as a novel target in cocaine use disorder.$405,230
R41 · FY2025 · DA · contact PI
Epigenetic mechanisms of sustained transcription across cocaine abstinence$680,143
R01 · FY2024 · DA · contact PI
Epigenetic regulation of Cdk5 in cognition and emotion$525,038
R01 · FY2024 · MH · contact PI
Epigenetic mechanisms of sustained transcription across cocaine abstinence$680,143
R01 · FY2023 · DA · contact PI
Epigenetic regulation of Cdk5 in cognition and emotion$499,571
R01 · FY2023 · MH · contact PI
Epigenetic mechanisms of sustained transcription across cocaine abstinence$686,803
R01 · FY2022 · DA · contact PI
Epigenetic mechanisms of sustained transcription across cocaine abstinence$679,084
R01 · FY2021 · DA · contact PI
Chromatin-mediated alternative splicing in reward pathophysiology$483,000
DP1 · FY2021 · DA · contact PI
Chromatin-mediated alternative splicing in reward pathophysiology$483,000
DP1 · FY2020 · DA · contact PI
Pharmacological activators of Nr4a1 for the treatment of cocaine use disorders$233,112
U18 · FY2020 · DA · contact PI
Chromatin-mediated alternative splicing in reward pathophysiology$483,000
DP1 · FY2019 · DA · contact PI
Chromatin-mediated alternative splicing in reward pathophysiology$71,834
DP1 · FY2019 · DA · contact PI
Chromatin-mediated alternative splicing in reward pathophysiology$483,000
DP1 · FY2018 · DA · contact PI
Chromatin-mediated alternative splicing in reward pathophysiology$71,834
DP1 · FY2018 · DA · contact PI
Chromatin-mediated alternative splicing in reward pathophysiology$483,000
DP1 · FY2017 · DA · contact PI
In Vivo Gene-Specific Regulation Using Engineered ZFPs in Drug Abuse$56,978
F32 · FY2014 · DA · contact PI
In Vivo Gene-Specific Regulation Using Engineered ZFPs in Drug Abuse$53,942
F32 · FY2013 · DA · contact PI